SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC

Position in ANIP — Ani Pharmaceuticals Inc

CIK 1446179 BALA CYNWYD, PA

Back to ANIP Full portfolio

Position in ANIP

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$723,911

-$242,847 QoQ

Shares Held

8,745

-39.4% QoQ

Ownership

0.038%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#154

of 303 holders

Holding Since

Dec 2020

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIP Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC holds $1,979,682 across 4 Drug Manufacturers - Specialty & Generic names. ANIP ranks #2 (36.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BCRX	Biocryst Pharmaceuticals Inc	91,228	$912,280
2	ANIP	Ani Pharmaceuticals Inc This page	8,745	$723,911
3	NBIX	Neurocrine Biosciences Inc	1,422	$239,663
4	EBS	Emergent BioSolutions Inc.	12,390	$103,828

All Filings in ANIP

Export CSV

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$723,911	8,745	-39.4%	Shares	Sole	2026-08-14
2025-03-31	$966,758	14,440	+302.5%	Shares	Sole	2025-05-14
2024-06-30	$228,483	3,588	-71.3%	Shares	Defined	2024-08-15
2020-12-31	$362,622	12,487	—	Shares	Defined	2021-02-16
No filing history on record for this holder in this stock.